Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Constellation Brands arrives at its October 7 print in a meaningfully different position than it occupied for the two prior previews: the stock has recovered to $115.67, up 2% on the day and 2.6% on the week, after weeks spent languishing below $115. The one-month decline is still a steep 9.8%, but the recent bounce means the market is no longer pricing in maximum pessimism quite as cleanly as it was when the PE sat near 9.3x. It now trades closer to 9.5x trailing earnings, with EV/EBITDA around 9.0x and a consensus mean target of roughly $161, implying about 39% upside. The lending market shows no sign of pressure: availability is extraordinarily loose at nearly 4,000%, with cost to borrow at just 0.36%. Short interest, at about 4.9% of the float, has risen around 19% over the past month but eased slightly on the week. Options positioning is neutral, with the put/call ratio at 0.83, fractionally below its 20-day average of 0.84 and well within its normal range.
The central tension going into today's print is that the analyst community has spent weeks cutting numbers while leaving ratings intact, and that pattern is now being tested by the stock's partial recovery. Wells Fargo's Chris Carey cut his target to $140 from $170 on October 5, even while holding Overweight, the most recent illustration of a dynamic that has played out across virtually every major firm since mid-September. RBC Capital's Nik Modi stands as the outlier, reiterating Outperform with a $185 target on October 2, the most bullish number on the Street. Between those poles, the direction of every other revision has been south. The bull case rests on Modelo and Corona's pricing power, management's FY27 EPS framework of $11.20 to $11.90, and a valuation that already discounts a great deal of deterioration. The bear case is structural: more than 90% of revenue comes from Mexican beer imports, leaving the company exposed to tariff risk, softening Hispanic-consumer spending, and a long-term category trajectory that consensus assumes is roughly flat to slightly negative. EPS momentum factor scores reinforce the caution, with the 30-day reading in the 23rd percentile.
One ownership shift adds texture to the setup. Warren Buffett's vehicle filed a 13G/A in May disclosing a reduction from 7.6% to 0.4% of the class, a dramatic exit from a position that had been closely watched as an implicit endorsement of the brand franchise. Positions are as last disclosed and holders dropping below 5% may not file again, so the current holding level is uncertain. Capital World Investors moved in the other direction, disclosing a climb from 3.8% to 7.2% in May. Neither shift changes the fundamental debate, but the Buffett exit removes one of the more prominent bullish data points the stock carried into 2025.
The print will test whether the October rally represents genuine re-rating or simply a short-covering bounce ahead of results, and whether management's guidance framework can hold against a beer category that has given investors little reason for optimism through the summer.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.